Nikki Martin on LUNGevity’s “No One Missed Campaign” Focusing on Biomarker Testing Access

Video

CancerNetwork® spoke with Nikki Martin of the LUNGevity Foundation regarding the “No One Missed” campaign working to provide education and awareness to patients with lung cancer.

CancerNetwork® recently spoke with Nikki Martin, director of Precision Medicine Initiatives at LUNGevity Foundation, regarding the recently launched No One Missed campaign.

The campaign focuses on helping patients gain access to valuable comprehensive biomarker testing, which can reveal the presence of driver mutations that are key in the treatment decision-making process.

“The No One Missed campaign is the latest evolution of our awareness and education programs for really targeting patients, but I can see how ultimately it could also become a provider-focused education and awareness campaign,” explained Martin. “what makes No One Missed unique is that it’s much broader than our previous education and awareness efforts. It’s a community-led program, so it’s not just LUNGevity Foundation running it, but we’re doing a lot more to pull in other stakeholders within the lung cancer ecosystem.”

LUNGevity Foundation is a nonprofit organization focusing on accelerating research and developing programs to remove barriers for patients with lung cancer accessing the necessary resources and care.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Video 4 - "Frontline Treatment for EGFR-Mutated Lung Cancer"
Video 3 - "NGS Testing Challenges and Considerations in NSCLC"
Related Content